These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37986881)

  • 1. Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence.
    Harris C; Joruiz S; Von Muhlinen N; Horikawa I; Gilbert M
    Res Sq; 2023 Nov; ():. PubMed ID: 37986881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence.
    Joruiz SM; Von Muhlinen N; Horikawa I; Gilbert MR; Harris CC
    Cell Death Dis; 2024 Jun; 15(6):454. PubMed ID: 38937431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence.
    Horikawa I; Fujita K; Jenkins LM; Hiyoshi Y; Mondal AM; Vojtesek B; Lane DP; Appella E; Harris CC
    Nat Commun; 2014 Aug; 5():4706. PubMed ID: 25144556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.
    Kang N; Wang Y; Guo S; Ou Y; Wang G; Chen J; Li D; Zhan Q
    BMC Cell Biol; 2018 Aug; 19(1):16. PubMed ID: 30126368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Δ133p53α Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity.
    Ungerleider K; Beck JA; Lissa D; Joruiz S; Horikawa I; Harris CC
    Neuroscience; 2022 Aug; 498():190-202. PubMed ID: 35716965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α.
    Roselle C; Horikawa I; Chen L; Kelly AR; Gonzales D; Da T; Wellhausen N; Rommel PC; Baker D; Suhoski M; Scholler J; O'Connor RS; Young RM; Harris CC; June CH
    Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2317735121. PubMed ID: 38408246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.
    Aoubala M; Murray-Zmijewski F; Khoury MP; Fernandes K; Perrier S; Bernard H; Prats AC; Lane DP; Bourdon JC
    Cell Death Differ; 2011 Feb; 18(2):248-58. PubMed ID: 20689555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
    Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA
    Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.
    Slatter TL; Hung N; Bowie S; Campbell H; Rubio C; Speidel D; Wilson M; Baird M; Royds JA; Braithwaite AW
    Cell Death Dis; 2015 Jun; 6(6):e1783. PubMed ID: 26068791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.
    Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Tumour Biol; 2014 May; 35(5):4567-80. PubMed ID: 24399651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF).
    Tan BS; Tiong KH; Choo HL; Chung FF; Hii LW; Tan SH; Yap IK; Pani S; Khor NT; Wong SF; Rosli R; Cheong SK; Leong CO
    Cell Death Dis; 2015 Jul; 6(7):e1826. PubMed ID: 26181206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity.
    Legscha KJ; Antunes Ferreira E; Chamoun A; Lang A; Awwad MHS; Ton GNHQ; Galetzka D; Guezguez B; Hundemer M; Bourdon JC; Munder M; Theobald M; Echchannaoui H
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34112738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells.
    Mondal AM; Zhou H; Horikawa I; Suprynowicz FA; Li G; Dakic A; Rosenthal B; Ye L; Harris CC; Schlegel R; Liu X
    Cell Death Dis; 2018 Jul; 9(7):750. PubMed ID: 29970881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells.
    Dong P; Tada M; Hamada J; Nakamura A; Moriuchi T; Sakuragi N
    Clin Exp Metastasis; 2007; 24(6):471-83. PubMed ID: 17636407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.
    Ju Q; Zhao L; Gao J; Zhou L; Xu Y; Sun Y; Zhao X
    Chin J Cancer Res; 2019 Jun; 31(3):533-546. PubMed ID: 31354222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
    Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
    Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An N
    Uddin MB; Roy KR; Hosain SB; Khiste SK; Hill RA; Jois SD; Zhao Y; Tackett AJ; Liu YY
    Biochem Pharmacol; 2019 Feb; 160():134-145. PubMed ID: 30578766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer.
    Zeitler L; Murray PJ
    J Biol Chem; 2023 Jun; 299(6):104827. PubMed ID: 37196768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis.
    Sun S; Chen H; Sun L; Wang M; Wu X; Xiao ZJ
    Cell Death Dis; 2020 Jul; 11(7):595. PubMed ID: 32733026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.